AZD9773 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Severe Sepsis
Conditions
Severe Sepsis, Septic Shock
Trial Timeline
Oct 1, 2010 → May 1, 2012
NCT ID
NCT01145560About AZD9773 + Placebo
AZD9773 + Placebo is a phase 2 stage product being developed by AstraZeneca for Severe Sepsis. The current trial status is completed. This product is registered under clinical trial identifier NCT01145560. Target conditions include Severe Sepsis, Septic Shock.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01145560 | Phase 2 | Completed |
| NCT01144624 | Phase 2 | Completed |
Competing Products
20 competing products in Severe Sepsis